DIMSartorius Stedim Biotech S.A.
163.10EUR+1.30%Mkt Cap: 15.17B EURP/E: 56.49Last update: 2026-05-14

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; b…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)56.49
P/E (Forward)25.74
PEG1.38
P/B3.67
P/S5.08
EV/EBITDA21.80
EV/Revenue5.77
EPS (TTM)2.76
EPS (Forward)6.06
Cash Flow & Leverage
FCF Yield1.69%
FCF Margin8.58%
Operating CF692.20M EUR
CapEx (TTM)393.20M EUR
Net Debt/EBITDA2.65
Net Debt2.09B EUR
Technical
SMA 50167.74 (-2.8%)
SMA 200185.74 (-12.2%)
Beta1.09
S&P 52W Chg24.23%
Avg Vol (30d)106.17K
Avg Vol (10d)86.34K
Technical Indicators
RSI (14)46.9
MACD-2.7217
MACD Signal-2.7509
MACD Hist.+0.0292
BB Upper190.80 EUR
BB Middle166.84 EUR
BB Lower142.88 EUR
BB Width28.72%
ATR (14)6.804 EUR
Vol Ratio (20d)1.37x
52W Range
150.0018% of range224.00
52W High224.00 EUR
52W Low150.00 EUR
Profitability
Gross Margin45.33%
EBITDA Margin26.46%
Profit Margin8.95%
Oper. Margin19.61%
ROE6.49%
ROA3.33%
Revenue Growth2.30%
Earnings Growth3.40%
Balance Sheet
Debt/Equity0.64
Current Ratio1.03
Quick Ratio0.51
Book Value/Sh42.44 EUR
Cash/Share5.384 EUR
Dividends
Fwd Div Rate0.6900 EUR
Trail. Div Rate0.0000 EUR
Div. Yield0.44%
5Y Avg Yield0.39%
Payout Ratio25.00%
Ex-Div DateMar 31, 2026
Pay Date
Splits
Last Split6:1
Split DateMay 6, 2016
Ownership
Shares Out.97.28M
Float27.60M
Insiders71.50%
Institutions11.85%
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)232.43 EUR
Target Range210.00 EUR262.00 EUR
# Analysts14
Company
Market Cap15.17B EUR
Enterprise Value17.22B EUR
Revenue (TTM)2.98B EUR
Gross Profit1.35B EUR
Net Income (TTM)265.60M EUR
Revenue/Share30.71 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10.5K
Last Price163.10 EUR
CountryFR
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINFR0013154002